|
1.
|
|
9 p, 981.6 KB |
A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus- and Sirolimus-based Graft-versus-Host Disease Prophylaxis
/
Piñana, J.L. (Hospital Universitari i Politècnic La Fe (València)) ;
Perez-Pitarch, A. (Hospital Clínico Universitario de València) ;
Garcia Cadenas, Irene (Institut d'Investigació Biomèdica Sant Pau) ;
Barba, Pere (Hospital Universitari Vall d'Hebron) ;
Hernandez-Boluda, J.C. (Fundación de Investigación INCLIVA) ;
Esquirol, Albert (Institut d'Investigació Biomèdica Sant Pau) ;
Fox, Maria Laura (Hospital Universitari Vall d'Hebron) ;
Terol, M.J. (Fundación de Investigación INCLIVA) ;
Queraltó, Josep M. (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
Vima, Jaume (Hospital Universitari Vall d'Hebron) ;
Valcárcel, David (Hospital Universitari Vall d'Hebron) ;
Ferriols-Lisart, R. (Hospital Clínico Universitario de València) ;
Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ;
Solano, C. (Universitat de València) ;
Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
There is a paucity of data evaluating acute kidney injury (AKI) incidence and its relationship with the tacrolimus-sirolimus (Tac-Sir) concentrations in the setting of reduced-intensity conditioning (RIC) after allogeneic stem cell transplantation (allo-HSCT). [...]
2017 -  10.1016/j.bbmt.2017.03.035
Biology of blood and marrow transplantation, Vol. 23 Núm. 7 (july 2017) , p. 1177-1185
|
|
|
2.
|
|
9 p, 318.7 KB |
Effect of a Perioperative Hypotension-Avoidance Strategy Versus a Hypertension-Avoidance Strategy on the Risk of Acute Kidney Injury : A Clinical Research Protocol for a Substudy of the POISE-3 Randomized Clinical Trial
/
Garg, Amit X. (London Health Sciences Centre) ;
Cuerden, Meaghan (London Health Sciences Centre) ;
Aguado, Hector (Hospital Clínico Universitario de Valladolid) ;
Amir, Mohammed (Shifa International Hospital) ;
Belley-Cote, Emilie P. (McMaster University (Canadà)) ;
Bhatt, Keyur (SIDS Hospital Research Centre) ;
Biccard, Bruce M (Groote Schuur Hospital) ;
Borges, Flavia K. (Population Health Research Institute) ;
Chan, Matthew (The Chinese University of Hong Kong) ;
Conen, David (Population Health Research Institute) ;
Duceppe, Emmanuelle (Population Health Research Institute) ;
Efremov, Sergey (Saint Petersburg State University) ;
Eikelboom, John (McMaster University (Canadà)) ;
Fleischmann, Edith (Medical University of Vienna) ;
Giovanni, Landoni (Istituto Scientifico Universitario San Raffaele) ;
Gross, Peter (McMaster University (Canadà)) ;
Jayaram, Raja (University of Oxford) ;
Kirov, Mikhail (Northern State Medical University of the Ministry of Healthcare of the Russian Federation) ;
Kleinlugtenbelt, Ydo (Deventer Ziekenhuis) ;
Kurz, Andrea (Medical University of Graz) ;
Lamy, Andre (Population Health Research Institute) ;
Leslie, Kate (The Royal Melbourne Hospital) ;
Likhvantsev, Valery (I. M. Sechenov Moscow Medical Academy) ;
Lomivorotov, Vladimir (Novosibirsk State University) ;
Marcucci, Maura (McMaster University (Canadà)) ;
Martinez-Zapata, Maria José (Institut d'Investigació Biomèdica Sant Pau) ;
McGillion, Michael (McMaster University (Canadà)) ;
McIntyre, William (Population Health Research Institute) ;
Meyhoff, Christian (University of Copenhagen) ;
Ofori, Sandra (Population Health Research Institute) ;
Painter, Thomas (Royal Adelaide Hospital) ;
Paniagua, Pilar (Institut d'Investigació Biomèdica Sant Pau) ;
Parikh, Chirag (Johns Hopkins University) ;
Parlow, Joel (Kingston General Hospital) ;
Patel, Ameen (McMaster University (Canadà)) ;
Polanczyk, Carisi (Hospital de Clinicas de Porto Alegre) ;
Richards, Toby (The University of Western Australia) ;
Roshanov, Pavel (Western University) ;
Schmartz, Denis (CHU Brugmann) ;
Sessler, Daniel (Cleveland Clinic) ;
Short, Tim (Auckland District Health Board) ;
Sontrop, Jessica M. (Western University) ;
Spence, Jessica (McMaster University (Canadà)) ;
Srinathan, Sadeesh (University of Manitoba) ;
Stillo, David (Population Health Research Institute) ;
Szczeklik, Wojciech (Jagiellonian University) ;
Tandon, Vikas (McMaster University (Canadà)) ;
Torres, David (Clinica Santa Maria (Chile)) ;
Van Helder, Thomas (Hamilton Health Sciences) ;
Vincent, Jessica (Population Health Research Institute) ;
Wang, C.Y. (University of Malaya) ;
Wang, Michael (McMaster University (Canadà)) ;
Whitlock, Richard (Population Health Research Institute) ;
Wittmann, Maria (Universitätsklinikum Bonn) ;
Xavier, Denis (St. John's National Academy of Health Sciences) ;
Devereaux, P. J (McMaster University (Canadà))
Background: Most patients who take antihypertensive medications continue taking them on the morning of surgery and during the perioperative period. However, growing evidence suggests this practice may contribute to perioperative hypotension and a higher risk of complications. [...]
2022 - 10.1177/20543581211069225
Canadian Journal of Kidney Health and Disease, Vol. 9 (january 2022)
|
|
|
3.
|
|
11 p, 983.1 KB |
Serial Urinary C-C Motif Chemokine Ligand 14 and Risk of Persistent Severe Acute Kidney Injury
/
Prowle, John R. (Queen Mary University of London) ;
Artigas Raventós, Antoni (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Bagshaw, Sean M. (University of Alberta) ;
Forni, Lui G. (University of Surrey and Royal Surrey County Hospital NHS Foundation Trust, Guildford) ;
Heung, Michael (University of Michigan) ;
Hoste, Eric (Ghent Universit) ;
Marlies, Ostermann (King's College London) ;
Koyner, Jay L. (University of Chicago) ;
Chawla, Lakhmir S (Veterans Affairs Medical Center) ;
Kampf, J. Patrick (Astute Medical (Estats Units d'Amèrica)) ;
Kwan, Thomas (University of Pittsburgh) ;
McPherson, Paul (Astute Medica (Estats Units d'Amèrica)) ;
Kellum, John A. (University of Pittsburg)
Retrospective observational study. Data derived from two multinational ICU studies (Ruby and Sapphire). Critically ill patients with early stage 2-3 AKI. None. We analyzed three consecutive uCCL14 measurements at 12-hour intervals after diagnosis of stage 2-3 AKI by Kidney Disease Improving Global Outcomes criteria. [...]
2023 - 10.1097/CCE.0000000000000870
Critical Care Explorations, Vol. 5 (march 2023)
|
|
|
4.
|
|
11 p, 703.6 KB |
Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
/
Buxeda, Anna (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Arias Cabrales, Carlos E (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Pérez-Sáez, María josé (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Cacho, Judit (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Cabello Pelegrin, Sheila (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Melilli, Edoardo (Hospital Universitari de Bellvitge) ;
Aladrén, María José (Hospital Universitario Miguel Servet (Saragossa)) ;
Galeano Alvarez, Cristina (Instituto Ramón y Cajal de Investigación Sanitaria (Madrid)) ;
Lorenzo, Iinmaculada (Complejo Hospitalario Universitario de Albacete) ;
Mazuecos, Auxiliadora (Hospital Universitario Puerta del Mar (Cadis, Andalusia)) ;
Saura, Isabel María (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
Franco, Antonio (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Ruiz-Fuentes, María del Carmen. (Hospital Universitario Virgen de las Nieves (Granada)) ;
Sánchez-Cámara, Luis Alberto (Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM)) ;
Siverio, Orlando (Hospital Universitario Nuestra Señora de Candelaria (Santa Cruz de Tenerife)) ;
Martin, María Luisa (Hospital Arnau de Vilanova (Lleida, Catalunya)) ;
González-García, Elena (Hospital Universitario La Paz (Madrid)) ;
López, Verónica (Instituto de Investigación Biomédica de Málaga) ;
Martin-Moreno, Paloma Leticia (Instituto de Investigación Sanitaria de Navarra) ;
Moina, Iñigo (Hospital de Basurto (Bilbao, Biscaia)) ;
Moral Berrio, Esperanza (Hospital General Universitario de Ciudad Real) ;
Moreso, Francesc (Hospital Universitari Vall d'Hebron) ;
Portolés, José María (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Santana-Estupiñán, Raquel (Hospital Universitario de Gran Canaria Dr. Negrín) ;
Zárraga, Sofía (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Canal Girol, Cristina (Institut d'Investigació Biomèdica Sant Pau) ;
Sánchez-Álvarez, Emilio (Hospital Universitario de Cabueñes (Gijón)) ;
Pascual, Julio (Pascual Santos) (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Crespo, Marta (Institut Hospital del Mar d'Investigacions Mèdiques)
Introduction: Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury have been reported. [...]
2021 - 10.1016/j.ekir.2021.06.023
Kidney International Reports, Vol. 6 Núm. 9 (september 2021) , p. 2305-2315
|
|
|
5.
|
|
8 p, 961.6 KB |
External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury
/
Bagshaw, Sean M. (University of Alberta) ;
Al-Khafaji, Ali (University of Pittsburgh) ;
Artigas Raventós, Antoni (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Davison, Danielle (George Washington University) ;
Haase, Michael (Otto Von-Guericke-University Magdeburg) ;
Lissauer, Matthew (Rutgers-Robert Wood Johnson Medical School) ;
Zacharowski, Kai (Goethe University) ;
Chawla, Lakhmir S. (Veterans Affairs Medical Center) ;
Kwan, Thomas (Astute Medical (Estats Units d'Amèrica)) ;
Kampf, J. Patrick (Astute Medical (Estats Units d'Amèrica)) ;
McPherson, Paul (Astute Medical (Estats Units d'Amèrica)) ;
Kellum, John A. (University of Pittsburgh) ;
Universitat Autònoma de Barcelona
Persistent acute kidney injury (AKI) portends worse clinical outcomes and remains a therapeutic challenge for clinicians. A recent study found that urinary C-C motif chemokine ligand 14 (CCL14) can predict the development of persistent AKI. [...]
2021 - 10.1186/s13054-021-03618-1
Critical Care, Vol. 25 (may 2021)
|
|
|
6.
|
|
|
7.
|
|
9 p, 990.4 KB |
Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with endotoxic shock : a case-control study
/
Navas Pérez, Ana Maria (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Ferrer, Ricard (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Martínez, Maria Luisa (Hospital Universitari General de Catalunya) ;
Gomà, Gemma (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Gili, Gisela (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Masip, Jordi (Hospital Universitari Sant Joan de Reus (Tarragona)) ;
Suárez, David (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Artigas Raventós, Antoni (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Universitat Autònoma de Barcelona
Septic shock is a leading cause of death in critical patients. In patients with gram-negative septic shock, hemoperfusion with polymyxin B aims to remove endotoxins from plasma. We analyzed the clinical and biological response to hemoperfusion in patients with septic shock and acute kidney injury. [...]
2018 - 10.1186/s13613-018-0465-8
Annals of Intensive Care, Vol. 8 (december 2018)
|
|
|
8.
|
|
14 p, 543.2 KB |
Finding the Dose for Ceftolozane-Tazobactam in Critically Ill Children with and without Acute Kidney Injury
/
Butragueño-Laiseca, Laura (Instituto de Salud Carlos III) ;
Troconiz, Iñaki (Instituto de Investigación Sanitaria de Navarra) ;
Grau, Santiago (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Campillo, Núria (Hospital del Mar (Barcelona, Catalunya)) ;
García-González, Xandra (Hospital General Universitario Gregorio Marañón) ;
Padilla, Belén (Hospital General Universitario Gregorio Marañón) ;
Fernández, Sarah N. (Instituto de Salud Carlos III) ;
Santiago, María José (Instituto de Salud Carlos III)
Background: Ceftolozane-tazobactam is a new antibiotic against multidrug-resistant pathogens such as Pseudomonas aeruginosas. Ceftolozane-tazobactam dosage is still uncertain in children, especially in those with renal impairment or undergoing continuous renal replacement therapy (CRRT). [...]
2020 - 10.3390/antibiotics9120887
Antibiotics, Vol. 9 (december 2020)
|
|
|
9.
|
|
15 p, 1.8 MB |
Predictive value of plasma proenkephalin and neutrophil gelatinase-associated lipocalin in acute kidney injury and mortality in cardiogenic shock
/
Jäntti, Toni (Helsinki University Hospital (Finlàndia)) ;
Tarvasmäki, Tuukka (Helsinki University Hospital (Finlàndia)) ;
Harjola, Veli-Pekka (Helsinki University Hospital (Finlàndia)) ;
Pulkki, Kari (Helsinki University Hospital (Finlàndia)) ;
Turkia, Heidi (Helsinki University Hospital (Finlàndia)) ;
Sabell, Tuija (Helsinki University Hospital (Finlàndia)) ;
Tolppanen, Heli (Helsinki University Hospital (Finlàndia)) ;
Jurkko, Raija (Helsinki University Hospital (Finlàndia)) ;
Hongisto, Mari (Helsinki University Hospital (Finlàndia)) ;
Kataja, Anu (Helsinki University Hospital (Finlàndia)) ;
Sionis, Alessandro (Institut d'Investigació Biomèdica Sant Pau) ;
Silva-Cardoso, Jose (University of Porto) ;
Banaszewski, Marek (National Institute of Cardiology, Warsaw, Poland) ;
DiSomma, Salvatore (University of Rome Sapienza) ;
Mebazaa, Alexandre (University Paris Diderot) ;
Haapio, Mikko (Helsinki University Hospital (Finlàndia)) ;
Lassus, Johan (Helsinki University Hospital (Finlàndia)) ;
Universitat Autònoma de Barcelona
Acute kidney injury (AKI) is a frequent form of organ injury in cardiogenic shock. However, data on AKI markers such as plasma proenkephalin (P-PENK) and neutrophil gelatinase-associated lipocalin (P-NGAL) in cardiogenic shock populations are lacking. [...]
2021 - 10.1186/s13613-021-00814-8
Annals of Intensive Care, Vol. 11 (february 2021)
|
|
|
10.
|
|
9 p, 369.1 KB |
Kidney transplantation and COVID-19 renal and patient prognosis
/
Toapanta, Néstor (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Torres, Irina B. (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Sellarés, Joana (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Chamoun, Betty (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Seron, Daniel (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Moreso, Francesc (Universitat Autònoma de Barcelona. Departament de Medicina)
Coronavirus disease 2019 (COVD-19) emerged as a pandemic in December 2019. Infection has spread quickly and renal transplant recipients receiving chronic immunosuppression have been considered a population at high risk of infection, complications and infection-related death. [...]
2021 - 10.1093/ckj/sfab030
Clinical Kidney Journal, Vol. 14 (march 2021) , p. i21-i29
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
